Stability of long-chain and short-chain 3-hydroxyacyl-CoA dehydrogenase activity in postmortem liver

Clinical Chemistry

Volumn 43, Issue 2, 1997, Pages 273-278

  Hale, Daniel E ^a   Cornell, John E ^a,b   Bennett, Michael J ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Rehabilitative Medicine Service   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

fatty acid oxidation; inherited metabolic disease; pediatric chemistry; rats; sample handling; sudden infant death syndrome

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; LONG CHAIN FATTY ACID; SHORT CHAIN FATTY ACID;

ANIMAL TISSUE; ARTICLE; CADAVER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME DEFICIENCY; ENZYME STABILITY; FATTY ACID OXIDATION; GENETIC COUNSELING; HUMAN; HUMAN TISSUE; INFANT; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; RAT; SUDDEN INFANT DEATH SYNDROME; TEMPERATURE;

ANIMALIA; APOGON BRACHYGRAMMUS;

EID: 0031022311     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.2.273     Document Type: Article

References (28)

1. Bennett MJ, Allison F, Pollitt RJ, Variend S. Fatty acid oxidation defects as causes of unexpected death in infancy. Prog Clin Biol Res 1990;321:349-64.
2. Bennett MJ, Powell S. Metabolic disease and sudden unexpected death in infancy. Hum Pathol 1994;25:742-6.
3. Busuttil A, Burchell A, eds. Sudden infant death syndrome. J Clin Pathol 1992;45(Suppl 11):1-48.
4. Anonymous. Sudden infant death and inherited disorders of fat oxidation [Editorial]. Lancet 1986;ii:1073-4.
5. Bennett MJ. The laboratory diagnosis of inborn errors of mitochondrial fatty acid oxidation. Ann Clin Biochem 1990;27:519-31.
6. Bennett MJ, Hale DE, Coates PM, Stanley CA. Postmortem recognition of fatty acid oxidation disorders. Pediatr Pathol 1991;11: 889-95.
7. Bennett MJ, Ragni MC, Hood I, Hale DE. Comparison of postmortem urinary and vitreous humor organic acids. Ann Clin Biochem 1992;29:541-5.
8. Boles RG, Martin SK, Blitzer MG, Rinaldo P. Biochemical diagnosis of fatty acid oxidation disorders by metabolic analysis of postmortem liver. Hum Pathol 1994;25:735-41.
9. Rashed MS, Ozand PT, Bennett MJ, Barnard JJ, Govindavaju DR, Rinaldo P. Fatty acid oxidation disorders and sudden death: diagnosis of inborn errors of metabolism in sudden death cases by acylcarnitine analysis of postmortem bile. Clin Chem 1995;41: 1109-14.
10. Uchida Y, Izai U, Orii T, Hashimoto T. Novel fatty acid β-oxidation enzymes in rat liver mitochondria II. Purification and properties of enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem 1992;167: 1034-41.
11. Carpenter K, Pollitt RJ, Middleton B. Human liver long-chain 3-hydroxyacyl-CoA dehydrogenase is a multifunctional membrane-bound β-oxidation enzyme of mitochondria. Biochem Biophys Res Commun 1992;183:443-8.
12. Hale DE, Bennett MJ. Fatty acid oxidation disorders: a new class of metabolic diseases [Review]. J Pediatr 1992;121:1-11.
13. Hale DE, Thorpe C, Braat K, Wright JH, Roe CR, Coates PM, et al. The long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Prog Clin Biol Res 1990;321:503-10.
14. Tein I, DeVivo DC, Hale DE, Clark JT, Zinman H. Laxer R, et al. Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause of recurrent myoglobinuria and encephalopathy. Ann Neurol 1991;30:415-9.
15. Treem WR, Rinaldo P, Hale DE, Stanley CA, Millington DS, Hyams JS, et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Hepatology 1994;19:339-45.
16. Sewell AC, Bender SW, Wirth S, Munterfering H, Ijlst L, Wanders RJ. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder. Eur J Pediatr 1994;153:745-50.
17. Ijlst L, Uskikubo S, Kamijo T. Hashimoto T, Ruiter JP, DeKlerk JB, Wanders RJ. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: high frequency of the G1528C mutation with no apparent correlation with clinical phenotype. J Inher Metab Dis 1995;18: 241-4.
18. Hagenfeldt L, Venizelos N, von Dobeln U. Clinical and biochemical presentation of long-chain 3 hydroxyacyl-CoA dehydrogenase deficiency. J Inher Metab Dis 1995;18:245-8.
19. Sims HF, Brackett JC, Powell CK, Treem WR, Hale DE, Bennett MJ, et al. The molecular basis of pediatric long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with acute fatty liver of pregnancy. Proc Natl Acad Sci U S A 1995;92:841-5.
20. Wanders RJA, Ijlst L, Poggi F, Bonnefont JP, Munnich A, Brivet M, et al. Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid oxidation. Biochem Biophys Res Commun 1992;188:1139-45.
21. Kirk RE, ed. Experimental design, 2nd ed. Monterey, CA: Brooks Cole Publishing, 1982:482pp.
22. Miller ME, Brooks JG, Forbes N, Insel R. Frequency of the medium-chain acyl-CoA dehydrogenase deficiency G-985 mutation in SIDS. Pediatr Res 1992;31:305-7.
23. Matsubara Y, Narisawa K, Tada K, Ikeda H, Yeqi Y, Danks D, et al. Prevalence of K329E mutation in the medium-chain acyl-CoA dehydrogenase gene determined by Guthrie cards. Prog Clin Biol Res 1992;375:453-62.
24. Wilcken B, Hammond J, Silink M. Morbidity and mortality in medium chain acyl-CoA dehydrogenase deficiency. Arch Dis Child 1994;70:410-12.
25. Rocchiccioli F, Wanders RJA, Auberg P, Vianey-Liaud C, Ijlst L, Fabre M, et al. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990;28:657-62.
26. Przyrembel H, Jakobs C, Ijlst L, deKlerk JBC, Wanders RJA. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inher Metab Dis 1991;14:674-80.
27. Jackson S, Singh Kler R, Bartlett K, Boggs A, Bindoff LA, Pourfarzam M, et al. Combined defect of mitochondrial fatty acid oxidation. J Clin Invest 1992;90:1219-25.
28. Bennett MJ, Weinberger MJ, Kobori JA, Rinaldo P, Burlina AB. Mitochondrial short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. A new defect of fatty acid oxidation. Pediatr Res 1996;39: 185-8.